Ⅵ. 論文業績
論文業績一覧
業績一覧
Ⅵ-1. 一元化登録（
一元化登録（2009 年 4 月以降）データ利用申請・月以降）データ利用申請・WG 研究 論文業績
論文業績
1.

加藤剛二.
小児へのさい帯血移植.

日本さい帯血バンクネットワーク設立 10 周年記念 そして明日から.2009:54-7. 【U1】2.

Mizuta S, Matsuo K, Yagasaki F, Yujiri T, Hatta Y, Kimura Y, Ueda Y, Kanamori H, Usui N, Akiyama H,
Miyazaki Y, Ohtake S, Atsuta Y, Sakamaki H, Kawa K, Morishima Y, Ohnishi K, Naoe T, Ohno R.
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem celltransplantation for BCR-ABL-positive acute lymphoblastic leukemia.

Leukemia. 2011;25(1):41-7. 【U2】3.

Takanashi M, Tanaka H, Kohsaki M, Nakajima K, Tadokoro K, Nakabayashi M.
A suggested total size for the cord blood banks of Japan.

Bone Marrow Transplant. 2011;46(7):1014-5. 【U3】4.

Ishiyama K, Takami A, Kanda Y, Nakao S, Hidaka M, Maeda T, Naoe T, Taniguchi S, Kawa K, Nagamura
T, Atsuta Y, Sakamaki H.
Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia with t(6;9)(p23;q34)
dramatically improves the patient prognosis: a matched-pair analysis.

Leukemia. 2012;26(3):461-4. 【U4】5.

Ishiyama K, Takami A, Kanda Y, Nakao S, Hidaka M, Maeda T, Naoe T, Taniguchi S, Kawa K, Nagamura
T, Tabuchi K, Atsuta Y, Sakamaki H.
Prognostic factors for acute myeloid leukemia patients with t(6;9)(p23;q34) who underwent an allogeneic
hematopoietic stem cell transplant.

Leukemia. 2012;26(6):1416-9. 【U5】6.

Fuji S, Nakamura F, Hatanaka K, Taniguchi S, Sato M, Mori S, Sakamaki H, Yabe H, Miyamoto T,
Kanamori H, Ueda Y, Kawa K, Kato K, Suzuki R, Atsuta Y, Tamaki T, Kanda Y.
Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft
failure after cord blood transplantation: a retrospective analysis of the registry data of the JapaneseSociety for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2012;18(9):1407-14. 【U6】7.

Kanda J, Hishizawa M, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, Tanosaki R, Kawano F, Miyazaki Y,
Masuda M, Nagafuji K, Hara M, Takanashi M, Kai S, Atsuta Y, Suzuki R, Kawase T, Matsuo K,
Nagamura-Inoue T, Kato S, Sakamaki H, Morishima Y, Okamura J, Ichinohe T, Uchiyama T.
Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for
adult T-cell leukemia: a retrospective cohort study.

Blood. 2012;119(9):2141-8. 【U7】8.

Kanda J, Saji H, Fukuda T, Kobayashi T, Miyamura K, Eto T, Kurokawa M, Kanamori H, Mori T, Hidaka
M, Iwato K, Yoshida T, Sakamaki H, Tanaka J, Kawa K, Morishima Y, Suzuki R, Atsuta Y, Kanda Y.
Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matchedunrelated transplantation: a nationwide retrospective study.

Blood. 2012;119(10):2409-16. 【U8】

9.

Kato M, Horikoshi Y, Okamoto Y, Takahashi Y, Hasegawa D, Koh K, Takita J, Inoue M, Kigasawa H,
Ogawa A, Sasahara Y, Kawa K, Yabe H, Sakamaki H, Suzuki R, Kato K.
Second allogeneic hematopoietic SCT for relapsed ALL in children.

Bone Marrow Transplant. 2012;47(10):1307-11.

【WGP 3-1】

10. Kobayashi R, Fujita N, Mitsui T, Iwasaki F, Suzumiya J, Kuroda H, Nishimura R, Sasahara Y, Takeshita Y,
Kato K, Okumura H, Sakamaki H, Yabe H, Kawa K, Kato K, Suzuki R.
Stem cell transplantation for paediatric patients with non-anaplastic peripheral T-cell lymphoma inJapan.

Br J Haematol. 2012;159(1):88-93. 【WGP 9-1】
11. Ishida T, Hishizawa M, Kato K, Tanosaki R, Fukuda T, Taniguchi S, Eto T, Takatsuka Y, Miyazaki Y,
Moriuchi Y, Hidaka M, Akashi K, Uike N, Sakamaki H, Morishima Y, Kato K, Suzuki R, Nishiyama T,
Utsunomiya A.
Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special
emphasis on preconditioning regimen: a nationwide retrospective study.

Blood. 2012;120(8):1734-41. 【WGP 13-1】
12. Hirokawa M, Fukuda T, Ohashi K, Hidaka M, Ichinohe T, Iwato K, Kanamori H, Murata M, Sakura T,
Imamura M, Adachi S, Suzuki R, Morishima Y, Sakamaki H; PRCA Collaborative Study Group.
Efficacy and long-term outcome of treatment for pure red cell aplasia after allogeneic stem celltransplantation from major ABO-incompatible donors.

Biol Blood Marrow Transplant. 2013;19(7):1026-32. 【U9】13. Kurosawa S, Yakushijin K, Yamaguchi T, Atsuta Y, Nagamura-Inoue T, Akiyama H, Taniguchi S,
Miyamura K, Takahashi S, Eto T, Ogawa H, Kurokawa M, Tanaka J, Kawa K, Kato K, Suzuki R,
Morishima Y, Sakamaki H, Fukuda T.
Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic celltransplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan
Transplant Outcome Registry.

Bone Marrow Transplant. 2013;48(4):529-36. 【U10】14. Kurosawa S, Yakushijin K, Yamaguchi T, Atsuta Y, Nagamura-Inoue T, Akiyama H, Taniguchi S,
Miyamura K, Takahashi S, Eto T, Ogawa H, Kurokawa M, Tanaka J, Kawa K, Kato K, Suzuki R,
Morishima Y, Sakamaki H, Fukuda T.
Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic celltransplantation in non-remission acute leukemia.

Bone Marrow Transplant. 2013;48(9):1198-204. 【U11】15. Shinzato A, Tabuchi K, Atsuta Y, Inoue M, Inagaki J, Yabe H, Koh K, Kato K, Ohta H, Kigasawa H, Kitoh
T, Ogawa A, Takahashi Y, Sasahara Y, Kato S, Adachi S.
PBSCT is associated with poorer survival and increased chronic GvHD than BMT in Japanese paediatricpatients with acute leukaemia and an HLA-matched sibling donor.

Pediatr Blood Cancer. 2013;60(9):1513-9. 【U12】16. Imahashi N, Suzuki R, Fukuda T, Kakihana K, Kanamori H, Eto T, Mori T, Kobayashi N, Iwato K, Sakura
T, Ikegame K, Kurokawa M, Kondo T, Iida H, Sakamaki H, Tanaka J, Kawa K, Morishima Y, Atsuta Y,
Miyamura K.
Allogeneic hematopoietic stem cell transplantation for intermediate cytogenetic risk AML in first CR.

Bone Marrow Transplant. 2013;48(1):56-62. 【U13】17. Sawada A, Ohga S, Ishii E, Inoue M, Okada K, Inagaki J, Goto H, Suzuki N, Koike K, Atsuta Y, Suzuki R,
Yabe H, Kawa K, Kato K, Yasutomo K.
Feasibility of reduced-intensity conditioning followed by unrelated cord blood transplantation for primary
hemophagocytic lymphohistiocytosis: a nationwide retrospective analysis in Japan.

Int J Hematol. 2013;98(2):223-30. 【U14】18. 永澤雅秀.
移植に必要な AB 型の血漿・血小板製剤の需給動向について.

血液事業.2013;35(4):703-5. 【U15】19. Chihara D, Ito H, Matsuda T, Katanoda K, Shibata A, Taniguchi S, Utsunomiya A, Sobue T, Matsuo K.
Association between decreasing trend in the mortality of adult T-cell leukemia/lymphoma and allogeneic
hematopoietic stem cell transplants in Japan: analysis of Japanese vital statistics and Japan Society for
Hematopoietic Cell Transplantation (JSHCT).

Blood Cancer J. (in press). 【U16】20. Murata M, Nishida T, Taniguchi S, Ohashi K, Ogawa H, Fukuda T, Mori T, Kobayashi H, Nakaseko C,
Yamagata N, Morishima Y, Nagamura-Inoue T, Sakamaki H, Atsuta Y, Suzuki R, Naoe T.
Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: ananalysis of the JSHCT.

Bone Marrow Transplant. (in press). 【U17】21. Muramatsu H, Sakaguchi H, Taga T, Tabuchi K, Adachi S, Inoue M, Kitoh T, Suminoe A, Yabe H, Azuma E,
Shioda Y, Ogawa A, Kinoshita A, Kigasawa H, Osugi Y, Koike K, Kawa K, Kato K, Atsuta Y, Kudo K.
Reduced intensity conditioning in allogeneic stem cell transplantation for AML with Down syndrome.

Pediatr Blood Cancer. (in press).

【WGP 1-1】

22. Kato M, Takahashi Y, Tomizawa D, Okamoto Y, Inagaki J, Koh K, Ogawa A, Okada K, Cho Y, Takita J,
Goto H, Sakamaki H, Yabe H, Kawa K, Suzuki R, Kudo K, Kato K.
Comparison of intravenous with oral busulfan in allogeneic hematopoietic stem cell transplantation withmyeloablative conditioning regimens for pediatric acute leukemia.

Biol Blood Marrow Transplant. 2013;19(12):1690-4.

【WGP 3-2】

23. Kanamori H, Mizuta S, Kako S, Kato H, Nishiwaki S, Imai K, Shigematsu A, Nakamae H, Tanaka M,
Ikegame K, Yujiri T, Fukuda T, Minagawa K, Eto T, Nagamura-Inoue T, Morishima Y, Suzuki R, Sakamaki
H, Tanaka J.
Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL
in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for
Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2013;48(12):1513-8.

【WGP 4-1】

24. Nishiwaki S, Miyamura K, Ohashi K, Kurokawa M, Taniguchi S, Fukuda T, Ikegame K, Takahashi S, Mori
T, Imai K, Iida H, Hidaka M, Sakamaki H, Morishima Y, Kato K, Suzuki R, Tanaka J; Adult Acute
Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: aretrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Societyfor Hematopoietic Cell Transplantation.

Ann Oncol. 2013;24(6):1594-602. 【WGP 4-2】
25. Tanaka J, Kanamori H, Nishiwaki S, Ohashi K, Taniguchi S, Eto T, Nakamae H, Minagawa K, Miyamura
K, Sakamaki H, Morishima Y, Kato K, Suzuki R, Nishimoto N, Oba K, Masauzi N.
Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45
years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for
Hematopoietic Cell Transplantation (JSHCT).

Bone Marrow Transplant. 2013;48(11):1389-94.

【WGP 4-3】

26. Kikuchi A, Yabe H, Kato K, Koh K, Inagaki J, Sasahara Y, Suzuki R, Yoshida N, Kudo K, Kobayashi R,
Tabuchi K, Kawa K, Kojima S.
Long-term outcome of childhood aplastic anemia patients who underwent allogeneic hematopoietic SCT
from an HLA-matched sibling donor in Japan.

Bone Marrow Transplant. 2013;48(5):657-60.

【WGP 11-1】

27. Ishida T, Hishizawa M, Kato K, Tanosaki R, Fukuda T, Takatsuka Y, Eto T, Miyazaki Y, Hidaka M, Uike N,
Miyamoto T, Tsudo M, Sakamaki H, Morishima Y, Suzuki R, Utsunomiya A.
Impact of Graft-versus-Host Disease on Allogeneic Hematopoietic Cell Transplantation for Adult T Cell
Leukemia-Lymphoma Focusing on Preconditioning Regimens: Nationwide Retrospective Study.

Biol Blood Marrow Transplant. 2013;19(12):1731-9.

【WGP 13-2】

28. Kanda Y, Kanda J, Atsuta Y, Maeda Y, Ichinohe T, Ohashi K, Fukuda T, Miyamura K, Iida H, Mori T,
Iwato K, Eto T, Kawa K, Morita S, Morishima Y.
Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bonemarrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLAWorking Group of the Japan Society for Blood and Marrow Transplantation.

Br J Haematol. 2013;161(4):566-77. 【WGP 17-1】
29. Tanaka J, Morishima Y, Takahashi Y, Yabe T, Oba K, Takahashi S, Taniguchi S, Ogawa H, Onishi Y,
Miyamura K, Kanamori H, Aotsuka N, Kato K, Kato S, Atsuta Y, Kanda Y.
Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without
ATG for acute leukemia in complete remission.

Blood Cancer J. (in press).

【WGP 17-2】

30. Atsuta Y, Kanda J, Takanashi M, Morishima Y, Taniguchi S, Takahashi S, Ogawa H, Ohashi K, Ohno Y,
Onishi Y, Aotsuka N, Nagamura-Inoue T, Kato K, Kanda Y; HLA Working Group of the Japan Society for
Hematopoietic Cell Transplantation.
Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation
between pediatric and adult patients with leukemia.

Haematologica. 2013;98(5):814-22. 【WGP 17-3】

31. Kanda J, Atsuta Y, Wake A, Ichinohe T, Takanashi M, Morishima Y, Taniguchi S, Takahashi S, Ogawa H,
Ohashi K, Ohno Y, Aotsuka N, Onishi Y, Kato K, Nagamura-Inoue T, Kanda Y; HLA Working Group of theJapan Society for Hematopoietic Cell Transplantation.
Impact of the direction of HLA mismatch on transplantation outcomes in single unrelated cord bloodtransplantation.

Biol Blood Marrow Transplant. 2013;19(2):247-54. 【WGP 17-4】
32. Kanda J, Ichinohe T, Kato S, Uchida N, Terakura S, Fukuda T, Hidaka M, Ueda Y, Kondo T, Taniguchi S,
Takahashi S, Nagamura-Inoue T, Tanaka J, Atsuta Y, Miyamura K, Kanda Y; Donor/Source Working
Group and HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in thegraft-versus-host direction.

Leukemia. 2013;27(2):286-94. 【WGP 18-1】
33. Murata M, Nakasone H, Kanda J, Nakane T, Furukawa T, Fukuda T, Mori T, Taniguchi S, Eto T, Ohashi K,
Hino M, Inoue M, Ogawa H, Atsuta Y, Nagamura-Inoue T, Yabe H, Morishima Y, Sakamaki H, Suzuki R.
Clinical factors predicting the response of acute graft-versus-host disease to corticosteroid therapy: ananalysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2013;19(8):1183-9.

【WGP 19-1】

34. Nakasone H, Kanda J, Yano S, Atsuta Y, Ago H, Fukuda T, Kakihana K, Adachi T, Yujiri T, Taniguchi S,
Taguchi J, Morishima Y, Nagamura T, Sakamaki H, Mori T, Murata M; GVHD Working Group of theJapan Society for Hematopoietic Cell Transplantation.
A case-control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem celltransplantation.

Transpl Int. 2013;26(6):631-9. 【WGP 19-2】
35. Nakasone H, Kurosawa S, Yakushijin K, Taniguchi S, Murata M, Ikegame K, Kobayashi T, Eto T,
Miyamura K, Sakamaki H, Morishima Y, Nagamura T, Suzuki R, Fukuda T.
Impact of hepatitis C virus infection on clinical outcome in recipients after allogeneic hematopoietic celltransplantation.

Am J Hematol. 2013;88(6):477-84. 【WGP 20-1】
36. Nakasone H, Onizuka M, Suzuki N, Fujii N, Taniguchi S, Kakihana K, Ogawa H, Miyamura K, Eto T,
Sakamaki H, Yabe H, Morishima Y, Kato K, Suzuki R, Fukuda T.
Pre-transplant risk factors for cryptogenic organizing pneumonia/bronchiolitis obliterans organizing
pneumonia after hematopoietic cell transplantation.

Bone Marrow Transplant. 2013;48(10):1317-23.

【WGP 20-2】

37. Kato M, Matsumoto K, Suzuki R, Yabe H, Inoue M, Kigasawa H, Inagaki J, Koh K, Hashii Y, Tauchi H,
Suminoe A, Kikuta A, Sakamaki H, Kawa K, Kato K, Fukuda T.
Salvage allogeneic hematopoietic SCT for primary graft failure in children.

Bone Marrow Transplant. 2013;48(9):1173-8. 【WGP 20-3】

38. Chihara D, Izutsu K, Kondo E, Sakai R, Mizuta S, Yokoyama K, Kaneko H, Kato K, Hasegawa Y, Chou T,
Sugahara H, Henzan H, Sakamaki H, Suzuki R, Suzumiya J.
High-dose chemotherapy with autologous stem cell transplantation for elderly patients withrelapsed/refractory diffuse large B-cell lymphoma: a nationwide retrospective study.

Biol Blood Marrow Transplant. (in press). 【WGP 10-1】
39. Kanda Y, Kanda J, Atsuta Y, Fuji S, Maeda Y, Ichinohe T, Takanashi M, Ohashi K, Fukuda T, Miyamura K,
Mori T, Sao H, Kobayashi N, Iwato K, Sawada A, Mori S; HLA working group of the Japan Society for
Hematopoietic Cell Transplantation.
Changes in the Clinical Impact of High-Risk Human Leukocyte Antigen Allele Mismatch Combinations on
the Outcome of Unrelated Bone Marrow Transplantation.

Biol Blood Marrow Transplant. (in press). 【WGP 17-5】
40. Kuwatsuka Y, Atsuta Y, Horowitz MM, Inagaki J, Kanda J, Kato K, Koh K, Zhang MJ, Eapen M;
Donor/Source Working Group and GVHD Working Group of the Japan Society for Hematopoietic Cell
Transplantation and the Center for International Blood and Marrow Transplant Research.
Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparisonof the Japanese versus Caucasian population.

Biol Blood Marrow Transplant. (in press). 【WGP 18-2】
41. Kanda J, Nakasone H, Atsuta Y, Toubai T, Yokoyama H, Fukuda T, Taniguchi S, Ohashi K, Ogawa H, Eto T,
Miyamura K, Morishima Y, Nagamura-Inoue T, Sakamaki H, Murata M.
Risk factors and organ involvement of chronic GVHD in Japan.

Bone Marrow Transplant. (in press).

【WGP 19-3】